Skip to content

Effect of Citric Acid Demineralization on Autogenous Bone Blocks Consolidation in Humans

Effect of Citric Acid Demineralization on Autogenous Bone Blocks Consolidation in Humans: Qualitative, Quantitative and Immunohistochemical Analysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03357068
Enrollment
10
Registered
2017-11-29
Start date
2017-07-01
Completion date
2018-12-22
Last updated
2023-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Atrophy, Bone Resorption

Brief summary

This study evaluates the effect of citric acid demineralization in autogenous bone blocks consolidation. Half of participants will receive citric acid treatment at the bone block and recipient site. Other half will receive no demineralization treatment.

Detailed description

Autogenous bone grafts are indicated in areas where there is not enough bone height and/or width for implant installation. Treatment of bone surfaces with citric acid, promote a slight demineralization on surface that mimic natural processes of bone demineralization by osteoclasts. Thus, this treatment could accelerate the process of autogenous bone block consolidation to its recipient site.

Interventions

PROCEDUREControl

Control side will receive only perforations on recipient site, which is the conventional technique for bone blocks graft.

PROCEDUREAcid

Test side will receive treatment with citric acid (10%) for 30s at bone block surface and recipient site

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Split mouth design - one side of mouth is test group, other side is control group

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Presence of atrophic anterior maxilla (width 1.5 to 4 mm) * Absence of active periodontal disease. * Enough bone width on donor sites (oblique line or ment)

Exclusion criteria

* Systemic disease that impede surgical procedure as blood diseases, endocrine diseases, impaired coagulation * Smokers * Pregnant women * Patients receiving radiotherapy or chemotherapy * Patients using bisphosphonates

Design outcomes

Primary

MeasureTime frameDescription
Clinical bone block consolidation5 monthsAbsence of fibrous tissue by clinical observation
Computerized tomography images bone block consolidation5 monthsAbsence of images compatible to fibrosis in cone beam computerized tomography images
Histological bone block consolidation5 monthsAbsence of fibrous tissue between bone block and recipient site in histological images.

Secondary

MeasureTime frameDescription
Bone width5 monthsMeasurement of bone width in mm on cone beam computerized tomography. Ideal if \>6 mm.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026